-
The Global ESG Rules and Regulations in the Pharmaceutical Industry: AstraZeneca Case Study
David Orchard Webb
April 21, 2025
In the dynamic pharmaceutical sector, where innovation and regulatory compliance have long been the pillars of success, a new disruptive force is emerging: Environmental, Social, and Governance (ESG) principles
-
InnoCare Sets up Specific Environment Management Target in its Fifth ESG Report
PharmaSources
April 28, 2024
InnoCare Pharma, a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases.
-
Global R&D Drug Development 2023: Overcoming Barriers, Bringing Hope to Patients and ESG focused
Shruti Talashi
January 02, 2024
As the global healthcare system refocuses after the pandemic, a recent report on the global R&D trend 2023 which was put together as a public service by the IQVIA Institute for Human Data Science.
-
Core8 Group and MedArmor to Pioneer Vietnam's First AI x ESG Hospital
PRNewswire
December 12, 2024
Core8 Group, an Australian leader in high-tech and biotech innovation, has unveiled plans to develop Vietnam's first AI x ESG Hospital, marking a significant milestone in healthcare transformation.
-
CatchMark Releases 2020 ESG Report
prnewswire
December 24, 2021
CatchMark Timber Trust, Inc. (NYSE: CTT) today released its 2020 ESG Report, which details the Company's deep commitment to meeting the highest standards of environmental stewardship...
-
BlueCity's 2020 ESG Report Highlights Its Unique LGBTQ-Driven Corporate Citizenship
prnewswire
December 09, 2021
BlueCity (Nasdaq: BLCT), a world-leading LGBTQ platform that provides a comprehensive suite of services aimed at fostering connection and enhancing the well-being of its global community, today released its 2020 ESG report.
-
Recro Pharma Appoints Erica Raether as VP of People, Culture and ESG
contractpharma
July 23, 2021
Raether has 20 years of human resources experience within the biotech and medical device industries.
-
Cryoport Launches ESG Program
contractpharma
March 02, 2021
Cryoport, Inc., a provider of temperature-controlled supply chain solutions for the life sciences industry, has launched its Environmental, Social & Governance (ESG) initiative.
-
Roche gets EC nod for Phesgo to treat HER2-positive breast cancer
pharmaceutical-business-review
December 30, 2020
Roche has secured approval from the European Commission (EC) for its Phesgo to treat early and metastatic HER2-positive breast cancer.
-
Roche’s breast cancer drug Phesgo secures US regulatory approval
pharmaceutical-technology
July 01, 2020
Roche has received approval from the US Food and Drug Administration (FDA) for Phesgo, in combination with intravenous (IV) chemotherapy, to treat early and metastatic human epidermal growth factor receptor 2 (HER2)-positive breast cancer.